Q: What is Emgality used for?

Emgality is used to treat migraine prevention and episodic cluster headache .

Q: How does Emgality work?

Understanding CGRP Emgality belongs to a class of medications known as calcitonin gene-related peptide (CGRP) antagonists. CGRP is a protein that occurs naturally in the body and is found in the brain and nervous system. Research suggests that CGRP plays a key role in the development of migraines and cluster headaches. During an attack, levels of CGRP often rise. This protein can cause blood vessels to widen and lead to inflammation, which contributes to the intense pain and other symptoms associated with these conditions. How Emgality Works Emgality is a monoclonal antibody, which is a protein designed to target a specific substance in the body. It works through the following process: Binding: Once injected, the medication circulates in the bloodstream and identifies the CGRP protein. Blocking: Emgality attaches itself directly to the CGRP protein. Prevention: By binding to the protein, the medication prevents CGRP from attaching to its receptors on the surface of cells. By interfering with this process, Emgality helps prevent the chain reaction that leads to migraine or cluster headache symptoms. Because it stays in the system for a long period, it is used as a preventive treatment to reduce how often attacks occur and how severe they are.

Q: What are the active ingredients in Emgality?

The active ingredient in Emgality is galcanezumab .

Q: What are the side effects of Emgality?

Common side effects of Emgality may include: Injection site reactions Constipation Always consult with a healthcare professional about potential side effects.

Q: What drug class is Emgality?

Emgality belongs to the CGRP antagonist drug class.

Q: Is Emgality safe during pregnancy and breastfeeding?

Pregnancy It is currently unknown whether Emgality can harm an unborn baby. Because there is limited data from clinical trials involving pregnant women, healthcare providers typically evaluate the necessity of the drug on a case-by-case basis. If you are pregnant or planning to become pregnant, consult your doctor to discuss the potential risks and benefits. Breastfeeding It is not known if galcanezumab, the active ingredient in Emgality, passes into breast milk or if it has any effect on a nursing infant. If you are breastfeeding or plan to breastfeed, talk with your healthcare provider about the risks and the best way to feed your baby while using this medication.

Q: What is the FDA approval status of Emgality?

FDA Approval History The U.S. Food and Drug Administration (FDA) first approved Emgality (galcanezumab-gnlm) in September 2018. It was initially indicated for the preventive treatment of migraine in adults. In June 2019, the FDA expanded its approved indications to include the treatment of episodic cluster headache in adults. Regulatory Safety Updates Following its market release, the FDA monitored reports of adverse events and identified potential safety signals that led to updates in the medication's official labeling: Hypersensitivity Reactions: In 2019, the FDA identified reports of serious hypersensitivity reactions, including anaphylaxis, angioedema, and rash. These risks were subsequently added to the prescribing information. Alopecia: In 2020, the FDA identified a potential signal for alopecia (hair loss) through its adverse event reporting system. This resulted in the inclusion of hair loss as a possible side effect in the product labeling. Emgality does not currently have a boxed warning, which is the FDA’s most serious type of warning, and it is not subject to a Risk Evaluation and Mitigation Strategy (REMS) program.

Question 1

What is Emgality?

Accepted Answer

This medication is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP), a protein involved in the transmission of pain signals. It is used to manage neurological conditions that cause severe headaches.

The therapy works by interfering with the biological pathways that contribute to headache development to reduce the frequency of episodes over time. It functions as a preventive measure rather than a treatment for immediate relief.

Question 2

What is Emgality used for?

Accepted Answer

Emgality is used to treat migraine prevention and episodic cluster headache.

Question 3

How does Emgality work?

Accepted Answer

Understanding CGRP

Emgality belongs to a class of medications known as calcitonin gene-related peptide (CGRP) antagonists. CGRP is a protein that occurs naturally in the body and is found in the brain and nervous system. Research suggests that CGRP plays a key role in the development of migraines and cluster headaches.

During an attack, levels of CGRP often rise. This protein can cause blood vessels to widen and lead to inflammation, which contributes to the intense pain and other symptoms associated with these conditions.

How Emgality Works

Emgality is a monoclonal antibody, which is a protein designed to target a specific substance in the body. It works through the following process:

Binding: Once injected, the medication circulates in the bloodstream and identifies the CGRP protein.
Blocking: Emgality attaches itself directly to the CGRP protein.
Prevention: By binding to the protein, the medication prevents CGRP from attaching to its receptors on the surface of cells.

By interfering with this process, Emgality helps prevent the chain reaction that leads to migraine or cluster headache symptoms. Because it stays in the system for a long period, it is used as a preventive treatment to reduce how often attacks occur and how severe they are.

Question 4

What are the active ingredients in Emgality?

Accepted Answer

The active ingredient in Emgality is galcanezumab.

Question 5

What are the side effects of Emgality?

Accepted Answer

Common side effects of Emgality may include:

Injection site reactions
Constipation

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Emgality?

Accepted Answer

Emgality belongs to the CGRP antagonist drug class.

Question 7

What is the dosage of Emgality and how do I take it?

Accepted Answer

How to Use Emgality

Emgality is given as an injection just under the skin (subcutaneously). It is typically injected into the abdomen, thigh, back of the upper arm, or buttocks. Your healthcare provider will show you or a caregiver how to prepare and inject the medication at home.

Preparation

Before using the medication, remove it from the refrigerator and let it sit at room temperature for at least 30 minutes. Do not shake the pen or syringe, and do not try to warm it up using a microwave or hot water. Check the liquid to ensure it is clear and colorless to slightly yellow; do not use it if it is cloudy, discolored, or contains large particles.

Dosing Schedule

For the prevention of migraines, the first dose usually consists of two separate injections given at the same time. After this initial dose, you will typically receive one injection once every month. For episodic cluster headaches, the medication is usually injected at the start of a cluster period and then once a month until the cluster period ends.

Missed Dose

If you miss a dose, administer the injection as soon as you remember. You should then schedule your next dose for one month after the date of your last injection. Do not take extra medication to make up for a missed dose.

Question 8

Is Emgality safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is currently unknown whether Emgality can harm an unborn baby. Because there is limited data from clinical trials involving pregnant women, healthcare providers typically evaluate the necessity of the drug on a case-by-case basis. If you are pregnant or planning to become pregnant, consult your doctor to discuss the potential risks and benefits.

Breastfeeding

It is not known if galcanezumab, the active ingredient in Emgality, passes into breast milk or if it has any effect on a nursing infant. If you are breastfeeding or plan to breastfeed, talk with your healthcare provider about the risks and the best way to feed your baby while using this medication.

Question 9

What forms and strengths does Emgality come in?

Accepted Answer

Emgality is supplied as a liquid solution for injection under the skin. It is available in the following delivery formats:

Prefilled pen
Prefilled syringe

These devices are intended for subcutaneous use and are designed to be discarded after use.

Question 10

What is the FDA approval status of Emgality?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) first approved Emgality (galcanezumab-gnlm) in September 2018. It was initially indicated for the preventive treatment of migraine in adults. In June 2019, the FDA expanded its approved indications to include the treatment of episodic cluster headache in adults.

Regulatory Safety Updates

Following its market release, the FDA monitored reports of adverse events and identified potential safety signals that led to updates in the medication's official labeling:

Hypersensitivity Reactions: In 2019, the FDA identified reports of serious hypersensitivity reactions, including anaphylaxis, angioedema, and rash. These risks were subsequently added to the prescribing information.
Alopecia: In 2020, the FDA identified a potential signal for alopecia (hair loss) through its adverse event reporting system. This resulted in the inclusion of hair loss as a possible side effect in the product labeling.

Emgality does not currently have a boxed warning, which is the FDA’s most serious type of warning, and it is not subject to a Risk Evaluation and Mitigation Strategy (REMS) program.

Question 11

What should I know about Emgality and cost?

Accepted Answer

Factors Influencing Cost

The price you pay for Emgality can vary significantly. Key factors include:

Insurance Coverage: Your out-of-pocket costs will depend on your specific health insurance plan, including your deductible, copayment, or coinsurance requirements.
Prior Authorization: Many insurance companies require prior authorization before they will cover the cost of Emgality. This means your doctor must provide documentation explaining why the medication is medically necessary for your condition.
Pharmacy Choice: Prices may differ between retail pharmacies, mail-order services, or specialty pharmacies.

Financial Assistance

For those without insurance or whose insurance does not cover the full cost, there may be options to reduce expenses:

Savings Cards: The manufacturer may offer savings cards for patients with commercial insurance to help lower monthly copays.
Patient Assistance Programs: Some programs provide the medication at a reduced cost or for free to individuals who meet specific income and eligibility requirements.

Generic and Biosimilar Availability

Emgality is a brand-name biologic medication. Currently, there are no generic or biosimilar versions of galcanezumab-gnlm available. Biologic drugs are more complex to manufacture than traditional drugs, and the lack of biosimilar alternatives generally keeps the cost higher.

Emgality

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Emgality

Hospitals.net Disclosure